Effects of Ezetimibe on Endothelial Progenitor Cells and Microparticles in High-Risk Patients


Imbalance on endothelial turnover can predict cardiovascular outcomes. We aimed at evaluating the effects of lipid-modifying therapies on circulating endothelial progenitor cells (EPCs), endothelial microparticles (EMPs), and platelet microparticles (PMPs) in high cardiovascular risk subjects with elevated C-reactive protein (CRP). Sixty-three individuals… (More)
DOI: 10.1007/s12013-014-9973-9


9 Figures and Tables